Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
  • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
  • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D233/91—Nitro radicals
  • C07D233/92—Nitro radicals attached in position 4 or 5
  • C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
  • A61K31/4164—1,3-Diazoles
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/0012—Galenical forms characterised by the site of application
  • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P17/00—Drugs for dermatological disorders
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P17/00—Drugs for dermatological disorders
  • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P17/00—Drugs for dermatological disorders
  • A61P17/06—Antipsoriatics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P17/00—Drugs for dermatological disorders
  • A61P17/10—Anti-acne agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• General Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• Medicinal Chemistry (AREA)
• Public Health (AREA)
• Pharmacology & Pharmacy (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Dermatology (AREA)
• Epidemiology (AREA)
• General Chemical & Material Sciences (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Rheumatology (AREA)
• Pain & Pain Management (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Medicinal Preparation (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=42790955

Family Applications (1)

Country Status (23)

Families Citing this family (1)

Family Cites Families (3)

• 2010
  • 2010-06-29 FR FR1055241A patent/FR2961809B1/fr not_active Expired - Fee Related
• 2011
  • 2011-06-29 PT PT117299727T patent/PT2588462E/pt unknown
  • 2011-06-29 IN IN515CHN2013 patent/IN2013CN00515A/en unknown
  • 2011-06-29 MX MX2012014632A patent/MX2012014632A/es active IP Right Grant
  • 2011-06-29 WO PCT/EP2011/060923 patent/WO2012001053A1/en active Application Filing
  • 2011-06-29 SI SI201130293T patent/SI2588462T1/sl unknown
  • 2011-06-29 ES ES11729972.7T patent/ES2518119T3/es active Active
  • 2011-06-29 BR BR112012032490A patent/BR112012032490A2/pt not_active IP Right Cessation
  • 2011-06-29 AR ARP110102285A patent/AR081783A1/es unknown
  • 2011-06-29 JP JP2013517271A patent/JP2013529667A/ja active Pending
  • 2011-06-29 DK DK11729972.7T patent/DK2588462T3/da active
  • 2011-06-29 US US13/806,719 patent/US8802710B2/en not_active Expired - Fee Related
  • 2011-06-29 RU RU2013103693/04A patent/RU2013103693A/ru not_active Application Discontinuation
  • 2011-06-29 CN CN2011800324626A patent/CN102958920A/zh active Pending
  • 2011-06-29 CA CA2801977A patent/CA2801977A1/en not_active Abandoned
  • 2011-06-29 AU AU2011273498A patent/AU2011273498A1/en not_active Abandoned
  • 2011-06-29 RS RS20140559A patent/RS53623B1/en unknown
  • 2011-06-29 EP EP11729972.7A patent/EP2588462B1/en not_active Not-in-force
  • 2011-06-29 PL PL11729972T patent/PL2588462T3/pl unknown
  • 2011-06-29 KR KR1020137001780A patent/KR20130088135A/ko not_active Application Discontinuation
• 2014
  • 2014-10-07 HR HRP20140966AT patent/HRP20140966T1/hr unknown
  • 2014-10-13 CY CY20141100831T patent/CY1115622T1/el unknown
  • 2014-11-13 SM SM201400174T patent/SMT201400174B/xx unknown

Also Published As

Similar Documents